AEON Biopharma, Inc. - Class A Common Stock (AEON)

37 filings reported holding AEON - AEON Biopharma, Inc. - Class A Common Stock as of Q4 2024.
AEON Biopharma, Inc. - Class A Common Stock (AEON) has 36 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 8.88M shares of 39.7M outstanding shares and own 22.35% of the company stock.
Largest 10 shareholders include Blue Owl Capital Holdings LP (3.05M shares), Polar Asset Management Partners Inc. (2.76M shares), VANGUARD GROUP INC (749K shares), Formidable Asset Management, LLC (689K shares), BlackRock, Inc. (266K shares), Ikarian Capital, LLC (258K shares), GEODE CAPITAL MANAGEMENT, LLC (252K shares), BANK OF AMERICA CORP /DE/ (167K shares), Caprock Group, LLC (62.7K shares), and STATE STREET CORP (61K shares).
This table shows the top 36 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.